256 related articles for article (PubMed ID: 31250463)
1. Characteristics of transfusion-transmitted Babesia microti, American Red Cross 2010-2017.
Tonnetti L; Townsend RL; Dodd RY; Stramer SL
Transfusion; 2019 Sep; 59(9):2908-2912. PubMed ID: 31250463
[TBL] [Abstract][Full Text] [Related]
2. Screening for Babesia microti in the U.S. Blood Supply.
Moritz ED; Winton CS; Tonnetti L; Townsend RL; Berardi VP; Hewins ME; Weeks KE; Dodd RY; Stramer SL
N Engl J Med; 2016 Dec; 375(23):2236-2245. PubMed ID: 27959685
[TBL] [Abstract][Full Text] [Related]
3. Transfusion-transmitted Babesia microti identified through hemovigilance.
Tonnetti L; Eder AF; Dy B; Kennedy J; Pisciotto P; Benjamin RJ; Leiby DA
Transfusion; 2009 Dec; 49(12):2557-63. PubMed ID: 19624607
[TBL] [Abstract][Full Text] [Related]
4. Lookback investigations of Babesia microti-seropositive blood donors: seven-year experience in a Babesia-endemic area.
Johnson ST; Cable RG; Leiby DA
Transfusion; 2012 Jul; 52(7):1509-16. PubMed ID: 21910741
[TBL] [Abstract][Full Text] [Related]
5. The impact of Babesia microti blood donation screening.
Tonnetti L; Townsend RL; Deisting BM; Haynes JM; Dodd RY; Stramer SL
Transfusion; 2019 Feb; 59(2):593-600. PubMed ID: 30499595
[TBL] [Abstract][Full Text] [Related]
6. Babesia microti seroprevalence in Minnesota blood donors.
Tonnetti L; Thorp AM; Deisting B; Bachowski G; Johnson ST; Wey AR; Hodges JS; Leiby DA; Mair D
Transfusion; 2013 Aug; 53(8):1698-705. PubMed ID: 23145838
[TBL] [Abstract][Full Text] [Related]
7. Seroprevalence of Babesia microti in blood donors from Babesia-endemic areas of the northeastern United States: 2000 through 2007.
Johnson ST; Cable RG; Tonnetti L; Spencer B; Rios J; Leiby DA
Transfusion; 2009 Dec; 49(12):2574-82. PubMed ID: 19821951
[TBL] [Abstract][Full Text] [Related]
8. Description of 15 DNA-positive and antibody-negative "window-period" blood donations identified during prospective screening for Babesia microti.
Moritz ED; Tonnetti L; Hewins ME; Berardi VP; Dodd RY; Stramer SL
Transfusion; 2017 Jul; 57(7):1781-1786. PubMed ID: 28453188
[TBL] [Abstract][Full Text] [Related]
9. Seroprevalence of Babesia microti infection in Canadian blood donors.
O'Brien SF; Delage G; Scalia V; Lindsay R; Bernier F; Dubuc S; Germain M; Pilot G; Yi QL; Fearon MA
Transfusion; 2016 Jan; 56(1):237-43. PubMed ID: 26426217
[TBL] [Abstract][Full Text] [Related]
10. Cost-effectiveness of blood donor screening for Babesia microti in endemic regions of the United States.
Simon MS; Leff JA; Pandya A; Cushing M; Shaz BH; Calfee DP; Schackman BR; Mushlin AI
Transfusion; 2014 Mar; 54(3 Pt 2):889-99. PubMed ID: 24252132
[TBL] [Abstract][Full Text] [Related]
11. Demonstrable parasitemia among Connecticut blood donors with antibodies to Babesia microti.
Leiby DA; Chung AP; Gill JE; Houghton RL; Persing DH; Badon S; Cable RG
Transfusion; 2005 Nov; 45(11):1804-10. PubMed ID: 16271108
[TBL] [Abstract][Full Text] [Related]
12. Babesia blood testing: the first-year experience.
Tonnetti L; Dodd RY; Foster G; Stramer SL
Transfusion; 2022 Jan; 62(1):135-142. PubMed ID: 34726279
[TBL] [Abstract][Full Text] [Related]
13. Preventing transfusion-transmitted babesiosis: preliminary experience of the first laboratory-based blood donor screening program.
Young C; Chawla A; Berardi V; Padbury J; Skowron G; Krause PJ;
Transfusion; 2012 Jul; 52(7):1523-9. PubMed ID: 22452654
[TBL] [Abstract][Full Text] [Related]
14. Prevalence of Babesia in Canadian blood donors: June-October 2018.
Tonnetti L; O'Brien SF; Grégoire Y; Proctor MC; Drews SJ; Delage G; Fearon MA; Brès V; Linnen JM; Stramer SL
Transfusion; 2019 Oct; 59(10):3171-3176. PubMed ID: 31385317
[TBL] [Abstract][Full Text] [Related]
15. Cost-effectiveness of Babesia microti antibody and nucleic acid blood donation screening using results from prospective investigational studies.
Bish EK; Moritz ED; El-Amine H; Bish DR; Stramer SL
Transfusion; 2015 Sep; 55(9):2256-71. PubMed ID: 25995054
[TBL] [Abstract][Full Text] [Related]
16. A novel quantitative PCR detects Babesia infection in patients not identified by currently available non-nucleic acid amplification tests.
Akoolo L; Schlachter S; Khan R; Alter L; Rojtman AD; Gedroic K; Bhanot P; Parveen N
BMC Microbiol; 2017 Jan; 17(1):16. PubMed ID: 28088177
[TBL] [Abstract][Full Text] [Related]
17. Risk of transfusion-transmitted Babesia microti in Canada.
O'Brien SF; Drews SJ; Yi QL; Bloch EM; Ogden NH; Koffi JK; Lindsay LR; Gregoire Y; Delage G
Transfusion; 2021 Oct; 61(10):2958-2968. PubMed ID: 34272882
[TBL] [Abstract][Full Text] [Related]
18. Investigational screening for Babesia microti in a large repository of blood donor samples from nonendemic and endemic areas of the United States.
Moritz ED; Winton CS; Johnson ST; Krysztof DE; Townsend RL; Foster GA; Devine P; Molloy P; Brissette E; Berardi VP; Stramer SL
Transfusion; 2014 Sep; 54(9):2226-36. PubMed ID: 24865803
[TBL] [Abstract][Full Text] [Related]
19. Transfusion-associated babesiosis in the United States: a description of cases.
Herwaldt BL; Linden JV; Bosserman E; Young C; Olkowska D; Wilson M
Ann Intern Med; 2011 Oct; 155(8):509-19. PubMed ID: 21893613
[TBL] [Abstract][Full Text] [Related]
20. Serologic screening of United States blood donors for Babesia microti using an investigational enzyme immunoassay.
Levin AE; Williamson PC; Bloch EM; Clifford J; Cyrus S; Shaz BH; Kessler D; Gorlin J; Erwin JL; Krueger NX; Williams GV; Penezina O; Telford SR; Branda JA; Krause PJ; Wormser GP; Schotthoefer AM; Fritsche TR; Busch MP
Transfusion; 2016 Jul; 56(7):1866-74. PubMed ID: 27224258
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
